world
Danish Drugmaker's Pill Hits 3 Million U.S. Prescriptions in 22 Weeks
The medication accumulated one million prescriptions within 12 weeks of U.S. availability and added two million more in the next 10 weeks.
usatoday.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
U.S. pharmacies and online providers 12 weeks after becoming available. The same medication added two million more prescriptions in the following 10 weeks, bringing the total to three million within 22 weeks of launch.
The Danish drugmaker issued a statement confirming the prescription milestones. The statement noted the one-million mark at the 12-week point and the additional two million in the subsequent period. @WSJ reported the prescription totals and the timeline from availability through the 22-week mark.
Transparency
1 source · single source
CorroborationModerate · 1 source
